Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07103382 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 5, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Aug 2025 to Jun 26, 2025 · Eligibility criteria revised · Secondary endpoints: 28 to 30v2 Show 3 more changesShow less
    • Start date changed from estimate of Aug 2025 to Jun 26, 2025
    • Eligibility criteria revised
    • Secondary endpoints: 28 to 30

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To explore the safety and efficacy of attapulgite in the treatment of obese individuals or overweight/obese individuals with type 2 diabetes.
Trial Details
NCT Number NCT07103382
Lead Sponsor Second Xiangya Hospital of Central South University
Conditions Obesity
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov